Vinayak Shenoy

4.1k total citations · 1 hit paper
61 papers, 3.1k citations indexed

About

Vinayak Shenoy is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Vinayak Shenoy has authored 61 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 19 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Vinayak Shenoy's work include Renin-Angiotensin System Studies (25 papers), Pulmonary Hypertension Research and Treatments (17 papers) and Hormonal Regulation and Hypertension (13 papers). Vinayak Shenoy is often cited by papers focused on Renin-Angiotensin System Studies (25 papers), Pulmonary Hypertension Research and Treatments (17 papers) and Hormonal Regulation and Hypertension (13 papers). Vinayak Shenoy collaborates with scholars based in United States, Brazil and China. Vinayak Shenoy's co-authors include Mohan K. Raizada, Michael J. Katovich, Yanfei Qi, Anderson J. Ferreira, Yanfei Qi, Robson A.S. Santos, Joseph Francis, Colleen T. Cole‐Jeffrey, Carl J. Pepine and Monica M. Santisteban and has published in prestigious journals such as Circulation Research, American Journal of Respiratory and Critical Care Medicine and Diabetes.

In The Last Decade

Vinayak Shenoy

56 papers receiving 3.1k citations

Hit Papers

Hypertension-Linked Patho... 2016 2026 2019 2022 2016 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vinayak Shenoy United States 29 1.5k 1.1k 740 586 470 61 3.1k
Yoram Yagil Israel 28 1.3k 0.8× 957 0.8× 973 1.3× 292 0.5× 347 0.7× 96 3.7k
Tatsuo Kawai Japan 26 1.2k 0.8× 1.2k 1.0× 534 0.7× 374 0.6× 756 1.6× 61 3.9k
Susan B. Gurley United States 35 2.2k 1.4× 1.6k 1.4× 1.7k 2.3× 330 0.6× 461 1.0× 85 5.2k
Christine Maric United States 30 1.6k 1.0× 1.0k 0.9× 1.6k 2.1× 342 0.6× 312 0.7× 56 4.0k
Jia L. Zhuo United States 41 2.7k 1.7× 1.9k 1.6× 1.8k 2.4× 319 0.5× 515 1.1× 114 4.3k
Jorge F. Giani United States 32 1.2k 0.7× 976 0.9× 711 1.0× 175 0.3× 349 0.7× 73 2.7k
Thu H. Le United States 30 1.5k 1.0× 1.5k 1.3× 1.1k 1.5× 270 0.5× 264 0.6× 73 3.3k
Johannes Stegbauer Germany 29 997 0.6× 663 0.6× 564 0.8× 205 0.3× 313 0.7× 97 2.4k
Felipe Inserra Argentina 33 845 0.5× 790 0.7× 626 0.8× 276 0.5× 717 1.5× 88 3.1k
Chana Yagil Israel 23 1.1k 0.7× 707 0.6× 790 1.1× 121 0.2× 358 0.8× 67 2.7k

Countries citing papers authored by Vinayak Shenoy

Since Specialization
Citations

This map shows the geographic impact of Vinayak Shenoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinayak Shenoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinayak Shenoy more than expected).

Fields of papers citing papers by Vinayak Shenoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinayak Shenoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinayak Shenoy. The network helps show where Vinayak Shenoy may publish in the future.

Co-authorship network of co-authors of Vinayak Shenoy

This figure shows the co-authorship network connecting the top 25 collaborators of Vinayak Shenoy. A scholar is included among the top collaborators of Vinayak Shenoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinayak Shenoy. Vinayak Shenoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shenoy, Vinayak, et al.. (2024). S3282 A Novel Approach for Managing Blown Out Myotomy After POEM or Heller Myotomy Using Endoscopic Bands. The American Journal of Gastroenterology. 119(10S). S2198–S2198. 1 indexed citations
2.
Maerten‐Rivera, Jaime, et al.. (2022). Moving AACP Curriculum Quality Survey Results from Good to Great. American Journal of Pharmaceutical Education. 87(3). ajpe9004–ajpe9004.
3.
Shenoy, Vinayak, et al.. (2020). S1710 Signet Ring Cell Mucinous Adenocarcinoma of the Colon Manifesting as Intermittent Hiccups. The American Journal of Gastroenterology. 115(1). S882–S883.
4.
Steckelings, U. Muscha, Björn Dahlöf, Thomas Unger, et al.. (2018). Demonstration of Preclinical Efficacy in Pulmonary Fibrosis Models and of Clinical Safety, Tolerability, and Pharmacodynamic Effects of the First-in-Class Angiotensin AT2-Receptor Agonist Compound 21 (C21). University of Southern Denmark Research Portal (University of Southern Denmark). 1 indexed citations
5.
Rathinasabapathy, Anandharajan, Alana Horowitz, Ashok Kumar, et al.. (2018). The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury. Frontiers in Physiology. 9. 180–180. 51 indexed citations
6.
Bryant, Andrew J., Vinayak Shenoy, Chunhua Fu, et al.. (2017). Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology. 58(2). 170–180. 33 indexed citations
7.
Stewart, Daniel, Andrés M. Rubiano, Monica M. Santisteban, et al.. (2016). Hypertension-linked mechanical changes of rat gut. Acta Biomaterialia. 45. 296–302. 29 indexed citations
8.
Qi, Yanfei, Juan Zhang, Lei Wang, et al.. (2015). Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia. Journal of Molecular Medicine. 94(1). 37–49. 47 indexed citations
9.
Fraga-Silva, Rodrigo A., et al.. (2015). Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in Rats. Protein and Peptide Letters. 23(1). 9–16. 43 indexed citations
10.
Chhabra, Kavaljit H., et al.. (2013). ACE2 gene therapy decreases fibrosis in the pancreas of high fat diet‐fed mice. The FASEB Journal. 27(S1). 1 indexed citations
11.
Murça, Tatiane M., Sérgio Henrique Sousa Santos, Marcos Barrouin Melo, et al.. (2012). Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction. Regulatory Peptides. 177(1-3). 107–115. 64 indexed citations
12.
13.
Gupta, Dipankar, Vinayak Shenoy, Michael J. Katovich, & Mohan K. Raizada. (2012). 203. Critical Care Medicine. 40. 1–328. 1 indexed citations
14.
Qi, Yanfei, Hongwei Li, Vinayak Shenoy, et al.. (2011). Moderate cardiac‐selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury. Experimental Physiology. 97(1). 89–101. 52 indexed citations
15.
Qi, Yanfei, Vinayak Shenoy, Fong Wong, et al.. (2011). Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology. Experimental Physiology. 96(9). 863–874. 57 indexed citations
16.
Shenoy, Vinayak, Yanfei Qi, Rodrigo A. Fraga-Silva, et al.. (2010). The Angiotensin-Converting Enzyme 2/Angiogenesis-(1–7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 182(8). 1065–1072. 218 indexed citations
17.
Ferreira, Anderson J., Vinayak Shenoy, Yanfei Qi, et al.. (2010). Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases. Experimental Physiology. 96(3). 287–294. 96 indexed citations
18.
Ferreira, Anderson J., Vinayak Shenoy, Yoriko Yamazato, et al.. (2009). Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 179(11). 1048–1054. 197 indexed citations
19.
Qi, Yanfei, Xuan Liu, Hongwei Li, et al.. (2009). Selective tropism of the recombinant adeno‐associated virus 9 serotype for rat cardiac tissue. The Journal of Gene Medicine. 12(1). 22–34. 12 indexed citations
20.
Prada, J.A. Hernandez, Anderson J. Ferreira, Michael J. Katovich, et al.. (2008). Structure-Based Identification of Small-Molecule Angiotensin-Converting Enzyme 2 Activators as Novel Antihypertensive Agents. Hypertension. 51(5). 1312–1317. 218 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026